Search Results 111-120 of 14761 for anti-TNF drugs

1. Prior authorization process can have multiple negative impacts for gastroenterologists and patients with inflammatory bowel disease - Mayo Clinic

   ... agents and small-molecule drugs, early in the course of disease. ... Examining clinical and genetic factors that impact response to anti-TNF agents in patients ...

2. Lupus - Diagnosis & treatment - Mayo Clinic

   Treatment · Nonsteroidal anti-inflammatory drugs (NSAIDs). · Antimalarial drugs. · Corticosteroids. · Immunosuppressants. · Biologics.

3. Arthritis pain: Treatments absorbed through your skin - Mayo Clinic

   Topical nonsteroidal anti-inflammatory drugs. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a common treatment for osteoarthritis. But the kind you take ...

4. Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... Developing Antidrug Antibodies to Infliximab or Adalimumab in HLA DQ Alleles ... Previously received a positive ...

5. Antidepressants: Selecting one that's right for you - Mayo Clinic

   Medicine options to treat depression include SSRIs, SNRIs, atypical antidepressants, tricyclic antidepressants, MAOIs and other drugs.

6. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

   ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...

7. Pain medicines after surgery - Mayo Clinic

   Other medicines that can treat pain after surgery include the anti-anxiety medicine midazolam and the anti-seizure medicines gabapentin (Gralise, Horizant, ...

8. The microbiome, fecal microbiota transplants and inflammatory bowel disease - Mayo Clinic

   Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD · Article. Research establishes strong association between ...

9. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   This study will evaluate the efficacy and safety of two adalimumab induction regimens in subjects with moderately to severely active Crohn's disease and ...

10. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

    Related Content. Article. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD · Article. Research establishes ...